SAN DIEGO, June 02, 2025 -- BioAtla, Inc. (Nasdaq: BCAB) (the “Company”), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the...
Jayson Punwani will moderate a panel at the 2nd annual Kenan-Flagler Business School Health Care conference on financing innovation.
News | 10. 29. 2012
Jayson Punwani will moderate a panel at the 2nd annual Kenan-Flagler Business School Health Care conference on financing innovation.
